Wart Remover Salicylic Acid 18%

Description

Salicylic acid 18.0% is the active ingredient in this wart remover formulation. The product contains several inactive ingredients, including borneol, glycerin, podofilox, polyethylene glycol, and water. This combination is designed to effectively target and remove warts through the keratolytic action of salicylic acid.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, "cauliflower-like" surface appearance, while plantar warts are specifically located on the bottom of the foot and are noted for their tenderness and disruption of the footprint pattern.

This product should only be used if the user is certain that the skin condition being treated is a wart. There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed and the wart soaked in warm water for 5 minutes. Following this, the area must be dried thoroughly. One drop of the medication should be carefully applied at a time using an applicator, ensuring that each wart is sufficiently covered. After application, the area should be allowed to dry.

This process may be repeated once or twice daily as needed until the wart is removed, with treatment continuing for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product due to the increased risk of adverse effects. Application on irritated skin or any area that is infected or reddened is also contraindicated, as this may exacerbate the condition. Additionally, the product should not be applied to moles, birthmarks, hairy warts, genital warts, or warts located on the face or mucous membranes, as these areas may be sensitive or require specialized care.

Contact with the eyes must be avoided; in the event of exposure, the eyes should be flushed with water for 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory irritation.

Warnings and Precautions

For external use only. This product is flammable; therefore, it is imperative to keep it away from fire or flame. The bottle should be capped tightly and stored at room temperature, away from heat sources to prevent any risk of ignition.

General precautions must be observed when using this product. It is contraindicated for individuals with diabetes or those who have poor blood circulation. The product should not be applied to irritated skin or any area that is infected or reddened. Additionally, it is not recommended for use on moles, birthmarks, hairy warts, genital warts, or warts located on the face or mucous membranes.

In the event of persistent discomfort, it is advised to discontinue use and consult a healthcare professional for further evaluation and guidance.

Side Effects

Patients should be aware that the product is for external use only and is flammable. It is essential to keep the product away from fire or flame, and the bottle should be capped tightly and stored at room temperature, away from heat sources.

In the event that discomfort persists after application, patients are advised to stop using the product and consult a doctor for further guidance.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Salicylic Acid 18% (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical advice immediately or contact a Poison Control Center without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of WART REMOVER SALICYLIC ACID 18% during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks versus benefits before recommending this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the context of overdosage, it is important to note that the available sections of the drug insert do not provide specific information regarding potential overdosage scenarios.

Healthcare professionals are advised to exercise caution and consider the possibility of overdosage when administering the medication. In the absence of detailed guidance, it is recommended that clinicians monitor patients closely for any unusual symptoms or adverse reactions that may arise following administration.

In the event of suspected overdosage, standard supportive measures should be implemented. This includes ensuring the patient's safety, providing symptomatic treatment, and considering the need for further medical evaluation. Healthcare providers should remain vigilant and prepared to manage any complications that may occur as a result of overdosage, even in the absence of specific symptoms outlined in the drug insert.

For further management, consultation with a poison control center or a medical toxicologist may be beneficial to guide treatment decisions and ensure optimal patient care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical advice immediately or contact a Poison Control Center without delay.

Patients should be informed to avoid contact with the eyes while using this product. If the product accidentally gets into the eye, they should flush the eye with water for at least 15 minutes and seek medical attention if necessary.

It is also important to counsel patients to avoid inhaling vapors associated with this product. If they experience any discomfort that persists, they should stop using the product and consult a doctor for further guidance.

Storage and Handling

The product is supplied in a bottle that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, specifically within the range of 68-99°F (20-37℃). Proper storage conditions are essential to ensure the product's efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Wart Remover Salicylic Acid 18%, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)